KINDRED BIOSCIENCES INC Share · US4945771099 · KIN · A1XA6K (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Últimos análisis de IA sobre KINDRED BIOSCIENCES INC
Sin cotización
Perfil de la empresa para KINDRED BIOSCIENCES INC Acción
Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.
Datos de la empresa
Nombre KINDRED BIOSCIENCES INC
Empresa Kindred Biosciences, Inc.
Símbolo KIN
Sitio web
http://www.kindredbio.com
Mercado principal 
NASDAQ CAPITAL MARKET
NASDAQ CAPITAL MARKET
WKN A1XA6K
ISIN US4945771099
Tipo de valor Acción
Sector Healthcare
Industria Drug Manufacturers - Specialty & Generic
CEO Richard Chin
País Estados Unidos de América
Moneda USD
Empleados 0,1 T
Dirección 1555 Bayshore Hwy Ste 200, 94010 Burlingame
Fecha de OPV 2013-12-12
Símbolos de cotización
| Nombre | Símbolo |
|---|---|
| NASDAQ | KIN |
Otras acciones
Los inversores que tienen KINDRED BIOSCIENCES INC también tienen las siguientes acciones en su cartera:
